Insider Selling: Colgate-Palmolive (NYSE:CL) CFO Sells $4,273,535.10 in Stock

Colgate-Palmolive (NYSE:CLGet Free Report) CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Colgate-Palmolive Stock Performance

CL opened at $92.57 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market capitalization of $75.63 billion, a price-to-earnings ratio of 26.52, a P/E/G ratio of 3.22 and a beta of 0.42. The business’s 50-day moving average price is $100.91 and its two-hundred day moving average price is $98.37. Colgate-Palmolive has a 1 year low of $74.67 and a 1 year high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently bought and sold shares of the company. Tradewinds LLC. lifted its position in shares of Colgate-Palmolive by 3.9% in the third quarter. Tradewinds LLC. now owns 58,126 shares of the company’s stock worth $6,034,000 after purchasing an additional 2,170 shares in the last quarter. Intech Investment Management LLC lifted its position in Colgate-Palmolive by 48.9% during the 3rd quarter. Intech Investment Management LLC now owns 132,417 shares of the company’s stock worth $13,746,000 after buying an additional 43,481 shares in the last quarter. Cornerstone Advisors LLC boosted its stake in shares of Colgate-Palmolive by 8.8% during the 3rd quarter. Cornerstone Advisors LLC now owns 40,931 shares of the company’s stock worth $4,249,000 after buying an additional 3,300 shares during the last quarter. Moran Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 53.1% in the 3rd quarter. Moran Wealth Management LLC now owns 7,738 shares of the company’s stock valued at $803,000 after acquiring an additional 2,684 shares in the last quarter. Finally, EagleClaw Capital Managment LLC increased its position in shares of Colgate-Palmolive by 0.9% in the third quarter. EagleClaw Capital Managment LLC now owns 32,879 shares of the company’s stock valued at $3,413,000 after acquiring an additional 300 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Jefferies Financial Group downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $103.00 to $95.00 in a report on Wednesday, July 24th. Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $105.11.

Read Our Latest Research Report on CL

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.